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A Comparison of Outcomes After 8 and 12 Weeks
of Pulmonary Rehabilitation
Kimi Hasegawa, MS, PT; Mary Anne Riley, AS, RRT,2
Michael Fillyaw, MS, PT;' Burton D. Tepfer, MD'
'Brattleboro Memorial Hospital, Brattleboro, VT, 'Cheshire Medical Center, Keene, NH,
University of New England, Biddeford, ME

ABSTRACT
Purpose: To compare changes in functional exercise
capacity, dyspnea, functional status, and depression in
patients after 8 weeks (24 sessions) and 12 weeks (36 sessions) of pulmonary rehabilitation (PR). Methods: A
prospective sample of 31 participants in our PR program
completed outcome measures prior to and during the
eighth and twelfth weeks of the program. The 6-minute
walk test (6MWT) and a stairs climbing test (ST) measured
functional exercise capacity. Perceived dyspnea (PD) was
measured with a 6-20 scale. The Pulmonary Function Status Scale (PFSS) measured functional status, and the Cardiac Depression Scale (CDS) measured depression.
Results : Statistically significant improvements were seen in
the 6MWT, PD during 6MWT, and ST after 8 weeks and
after 12 weeks of PR, but the improvements between 8 and
12 weeks were small and not statistically significant. After
8 weeks, PFSS total scores suggested increased difficulty
carrying out daily tasks that moderated by 12 weeks. CDS
scores showed modest, but not statistically significant
improvements, after 8 and 12 weeks. Conclusion : Statistically significant and clinically important improvements in
6MWT, ST, and dyspnea occur after 8 weeks and 12 weeks
of PR, but the changes between 8 and 12 weeks were not
large enough to be statistically significant or clinically
important. Neither 8 nor 12 weeks was sufficient to produce statistically significant changes in functional status
and depression.
INTRODUCTION
Multidisciplinary pulmonary rehabilitation (PR) programs are accepted as an effective treatment for patients
with chronic lung disease. The primary goal of rehabilitation, to restore the patient to the highest possible level of
independent function, usually is accomplished by helping
patients to be more active through exercise training and to
reduce and gain control of symptoms.' A review of randomized controlled trials of pulmonary rehabilitation in
patients with chronic obstructive pulmonary disease
(COPD) concluded exercise relieves dyspnea and fatigue
and enhances patients' sense of control over their condiAddress correspondence to: Kimi Hasegawa, MS, PT,
Brattleboro Memorial Hospital, 17 Belmont Ave ., Brattleboro, VT 05301 Ph: 802-257-8255, FAX: 802-2573114 (kimih_ bmh@yahoo.com)
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tion and that rehabilitation forms an important component
of the management of COPD.' Despite general consensus
that pulmonary rehabilitation is efficacious, there is little
agreement about what constitutes the most effective and
efficient pulmonary rehabilitation program.'
The duration of PR programs varies widely. The evidence-based guidelines developed by the American College of Chest Physicians and American Association of Cardiovascular and Pulmonary Rehabilitation' were based on
14 controlled trials of lower extremity exercise training that
varied in duration from 4 weeks to 6 months. Similarly,
meta-analyses published by Lacasse et al' and Cambach et
al examined PR programs ranging in duration from 6
weeks to continuous. Lacasse et all concluded duration of
the program did not affect maximum exercise capacity
measured as peak workload (watts) during an incremental
cycle ergometer test. However, analysis of the effect of PR
on functional exercise capacity, measured as walking distance, showed heterogeneity among the study results. A
post-hoc analysis showed a significant difference between
programs of 6 months duration and shorter programs,
which Lacasse et al' hypothesized as the source of heterogeneity.
Pulmonary rehabilitation programs 8 weeks or less in
duration have shown varying results. Young et al' reported
statistically significant improvements in 6-minute walk distance, dyspnea, and quality of life measures after a 1month (7 sessions) program. However, increases in walk
distance did not reach the minimally clinically important
difference of 54 meters' until 3 months after completing the
formal rehabilitation program. Ringbaek et al" concluded
that their program of 8 weeks (16 sessions) was insufficient
to produce significant improvements in 6-minute walk distance or quality of life measures. Conversely, Singh et al9
found significant improvements in shuttle walking test distance, treadmill endurance, and quality of life measures
after 7 weeks (14 sessions) of PR.
Several studies have specifically examined the effect of
program duration. Green et al'° conducted a randomized
controlled trial of comparable twice-weekly PR programs
of 4 and 7 weeks duration. Subjects who completed the 7week program had greater improvements in all outcome
measures than those in the 4-week program. The differences in improvements reached statistical significance for
the total Chronic Respiratory Disease Questionnaire score
and the domains of dyspnea, emotion, and mastery. The 7week group improved in the shuttle walk and treadmill
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endurance test, but the differences between the 4 and 7week groups were not statistically significant. The authors
concluded that 7 weeks of PR provide greater benefit to
patients.
The randomized, controlled trial of Bendstrup et al" featured exercise training 3 times weekly for 12 weeks. Data
were collected at 6 and 12 weeks with a follow-up after 24
weeks. The increase in 6-minute walk distance was significant after 6 weeks, but further improvements were small.
This indicated a shorter PR program might be sufficient.
However, the differences between the control and treatment groups for the Activities of Daily Living score and the
Chronic Respiratory Disease Questionnaire score did not
become statistically significant until 12 and 24 weeks,
respectively.
The literature in pulmonary rehabilitation suggests that
shorter duration rehabilitation programs may be effective in
increasing functional exercise capacity and health status in
the short term. The purpose of our study was to compare
the outcomes of functional exercise capacity, dyspnea,
functional status, and depression of patients after 8 weeks
(24 sessions) and 12 weeks (36 sessions) of pulmonary
rehabilitation. Both pressure from third party payers and
our desire to serve as many patients as efficiently as possible led us to question whether we could attain similar outcomes in a shorter period.
METHODS
Study Design
The study was a one-way repeated measures design
with time as the independent variable. Subjects were
tested before PR, and during regularly scheduled sessions
of the program in the eighth week (sessions 22-24) and
eleventh or twelfth weeks (sessions 31-35). Due to scheduling problems, some data were collected in the session
immediately preceding or following the eighth week.
Walk distance data collected from previous patients
showed a mean difference of 76 m between the initial and
final tests. Since this exceeded the minimal clinically
important difference of 54 m,7 we used the latter value to
determine that a sample of 9 patients would provide 80%
power needed to detect a clinically important difference
between the initial and final walk tests at P < 0.05. Recognizing that the difference we observed might be less, and
allowing for some dropouts, all patients who started the PR
program during the study period were invited to participate.
Subjects
Forty-eight participants in a 12-week (36 sessions) multidisciplinary PR program of education and exercise were
invited to participate in this study. Admission criteria for the
program included a diagnosis of chronic obstructive pulmonary disease or restrictive pulmonary disease, physician
referral, tobacco free, and no acute cardiac disease. Data
from 31 patients who completed the program were analyzed. Of the remaining 17 patients, 10 did not complete
the program, 5 could not participate because their insurVol 16 No 3 September 2005

ance carriers required testing at intervals different from
those specified by the study protocol, 1 declined to participate in the study, and 1 was excluded due to problems
with data collection. The Institutional Review Board of the
Brattleboro Memorial Hospital approved the study and all
subjects provided written informed consent. Table 1 provides information about the subjects.
Table 1. Characteristics of Subjects
n Mean SD Range
Gender
Male 12
Female 19
Age (yr) 31 68.3 9.28 45 - 83
FEV, (% of predicted) 31 47.2 1 7.09 22 - 90
Primary diagnosis
Emphysema 20
Asthma 2
Chronic bronchitis 2
Pulmonary fibrosis 2
Bronchiectasis 1
Interstitial lung disease 1
Lung cancer 1
Restrictive lung disease 1
Sarcoidosis 1
FEV, = forced expiratory volume in one second

Measurement Procedures
Before beginning the PR program, all prospective participants were interviewed by the program coordinator and
completed the Pulmonary Function Status Scale (PFSS) and
Cardiac Depression Scale (CDS) with the assistance of the
coordinator, if needed. In addition, participants received a
physical therapy examination by the principal investigator
in the 30 days prior to starting PR. During this evaluation,
participants performed the initial 6-minute walk test
(6MWT) and timed stairs test (ST), and were introduced to
the perceived dyspnea scale (PD).
6 minute walk test (6MWT)
One of the most frequently used outcome measures for
PR programs, the 6MWT demonstrates good test-retest reliability and convergent validity with standard measures of
pulmonary impairment.12 Our subjects performed one
6MWT on a course 90 feet long and received standard
written instructions and verbal encouragement. Due to
space and time constraints, we were unable to use the recommended minimum 100-foot course or to conduct the
recommended 3 trials per test, a limitation common to
many PR programs."
Timed stairs test (ST)
Participants were timed while descending and ascending two flights of stairs as quickly as possible, using a
handrail if needed. The first flight had 10 steps and the second flight had 8 steps. The total vertical distance was 12
feet. This test resembles that of Rejeski et al'' except that
we timed both the descent and ascent of the stairs. Rejeski
et al 12 reported the reliability of repeated trials of the ST and
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its convergent validity with VO2peak, FEV,, and self- reported
disability in patients 55 to 80 years with COPD.

Perceived dyspnea (PD)
During the 6MWT and stairs test subjects rated their
dyspnea using a modification of the 6 - 20 Borg Rate of
Perceived Exertion scale.1415 To clarify to patients that they
were rating their dyspnea words describing breathing were
added to the descriptive phrases accompanying the scale.
Subjects rated their dyspnea at the start of the 6MWT, after
2 and 4 minutes, and at the end of the test. The final PD
was recorded for statistical analysis. During the ST subjects rated their dyspnea at completion of the test.

Pulmonary function status scale (PFSS)
The PFSS16 is a 35-item, self-administered questionnaire,
which assesses the functional status of patients with
chronic pulmonary disease. Three subscores, evaluating
daily activities/social functioning (22 items), psychological
functioning (10 items), and sexual functioning (3 items) are
calculated as well as a total score. Each subscore ranges
from 1-5; total score ranges from 3-15. A lower score
indicates more impaired functional status due to difficulty
in performing a specific activity, or performing the activity
less frequently. The PFSS has been shown to have content,
construct, and concurrent forms of validity and to have
test-retest reliability.16

Depression scale (CDS)
Developed to assess depression in cardiac patients, the
CDS" is a 26 item, self-administered questionnaire, with
each item measured on a 1 to 7 Lichert scale. Responses to
individual items related to sleep, anhedonia, uncertainty,
mood, cognition, hopelessness, and inactivity are summed
to a total score. A higher score indicates greater depression.

Pulmonary Rehabilitation Program
Participants received one hour of exercise and one hour
of education 3 times per week for 12 weeks. Heart rate,
blood pressure, oxygen saturation, and PD were monitored
before, during, and after the exercise session. Supplemental oxygen was provided to maintain oxygen saturation at
or above 88%. All exercises were modified to meet individual needs.
Aerobic exercise was performed utilizing the treadmill,
and at least one other type of exercise equipment (eg, stationary bicycle, upper body ergometer, rowing machine, or
Nustep) (Nustep Inc, 511 Venture Dr, Ann Arbor, MI). Each
participant received an exercise prescription set by the PR
medical director at 75% to 85% of the maximal workload
achieved during a preprogram graded exercise stress test.
After beginning exercise at a subtherapeutic level to
become familiar with the equipment and to increase
endurance to 20 minutes, participants were instructed to
increase exercise intensity to maintain a 13 - 15 level
('somewhat short of breath' to 'short of breath') on the PD
scale. Each participant progressed to 20 to 40 continuous
12

minutes of aerobic exercise and exceeded the maximum
workload they achieved during the exercise stress test.
Participants also performed progressive resistance exercises for the arms with weights ranging from 1 pound hand
weights to 18 pound exercise bars and standing leg exercises. Participants were instructed to increase resistance so
that they would feel challenged by 1 set of 10 repetitions
of each exercise. Static stretching exercises for the arms
and legs were also included.
The PR coordinator, a respiratory therapist, directed the
multidisciplinary educational component. Educational
topics included lung anatomy and physiology, pulmonary
diseases, medications, nutrition, breathing techniques,
lung function tests, exercise stress testing and exercise prescription, stress reduction, home exercise, energy conservation in daily activities, and advance directives. Experts
from the hospital or community, including the PR coordinator, physical therapists, occupational therapists, registered dieticians, pharmacists, psychologists, and hospice
representatives, lead the educational sessions. Weekly support group sessions were also provided.
Data Analysis
Thirty-one patients completed the study. Some subjects
did not complete all tests at the 3 time-points, however, so
statistical tests were performed on variables for which
complete data were available. Probability plots and
one-sample Kolmogorov-Smirnov tests were analyzed to
determine if the sampled populations were normally
distributed before computing inferential statistics.16
Because the variable 6MWT was normally distributed,
differences in walk distance at the 3 test periods were
analyzed using one-way analysis of variance for repeated
measures followed by paired t-tests for multiple comparisons. The variable ST was not normally distributed, so the
differences were analyzed by the Friedman test followed by
Wilcoxon Signed Ranks test. Because PD, PFSS, and CDS
are ordinal-level measurements, the differences among
3 tests were analyzed using the Friedman test followed
by Wilcoxon Signed Ranks tests for paired multiple comparisons. Data were analyzed using Systat Version 10.0
(Systat Software Inc, 501 Canal Blvd, Point Richmond,
Calif) statistical software.
RESULTS
Table 2 summarizes the results for each measure.
Six-Minute Walk Test
Thirty-one patients completed all 3 tests. The mean distance walked was significantly different between the 3 tests
(P < 0.001). The mean distance increased by 50 meters
(95% Cl = 36.8 - 63.1, P < 0.001) after 8 weeks of PR and
by 60 meters (95% Cl = 42.1 - 77.9, P < 0.001) after 12
weeks. The mean increase of 10.1 meters (95% Cl = -5.5
- 25.7) between weeks 8 and 12 was not significant (P =
0.196).
There were significant differences in PD during the 3
walk tests (P < 0. 001). The median PD decreased from 15
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clinical importance for the 6MWT. In
addition, our results are consistent with
N
12
weeks
Initial
8
weeks
Measurement
Cambach et all and Lacasse et a14 who
reported average improvements in
31
310.2 ± 88.3
6MWT (m)
360.1 ± 101.7*
370.2 ± 110.8*
walking
distance of 49 m and 56 m
13.0*
13.0*
6MWT PD
31
15.0
respectively.
29
33.2 ± 20.6
27.3 ± 10.9*
26.4 ± 12.3*
ST (s)
Although the increase in mean dis11.0
12.0
11.0
ST PD
29
tance of 10.1 m from week 8 to week
7.8
8.4
PFSS Total
26
9.9
12 was not statistically significant, some
26
Activities/Social Function
3.7
3.7
3.5
patients
and clinicians might consider
26
4.1
4.0
3.8
Psychological Function
the increase to be clinically important.
4.0
10
3.5
3.5
Sexual Function
The 95% confidence interval (-5.5 97.0
96.5
92.0
28
CDS
25.7 meters) for the mean of 10.1 indi* Measurements at 8 and 12 weeks are significantly different as compared to initial test (P <0.001),
cates
the data are consistent with the
but are not different from each other.
interpretation that walk distance may
6MWT = 6-Minute Walk Test. Values are mean ± standard deviation
decrease or increase between weeks
PD = Perceived Dyspnea. Values are medians
ST = Stairs Test. Values are mean ± standard deviation
and 8 and 12 of PR. Thus, our data are
PFSS = Pulmonary Function Status Scale. Values are medians
not conclusive on this question. A
CDS = Cardiac Depression Scale. Values are medians
trend analysis19 using single degree of
freedom polynomial contrasts was per"short of breath" to 13 "somewhat short of breath" at 8
formed to further elucidate the changes in walk distance
weeks (P = 0.001) and remained at this level at 12-weeks.
during PR. This analysis revealed a quadratic trend across
the 3 tests (p = 0.05), meaning the improvement in walk
Stairs Test
distance is not linear (Figure 1). It appears that most of the
Twenty-nine patients completed all 3 tests. The time
changes in patient motivation, pacing skills, and peripheral
required to descend and climb stairs was significantly difmuscle and cardiac conditioning brought about by particiferent between the 3 tests (P < 0. 001). The average time
pation in PRZ° occur by 8 weeks. It is also likely that difdecreased by 6 seconds (95% Cl = 0.87 - 1 1.0, P < 0.001)
ferences in patients' ages, severity of disease, and co-morafter 8 weeks and by 7 seconds (95% Cl = 0.71 - 12, P <
bidities may affect the rate of change for the 6MWT and
0.001) after 12 weeks. The difference of 0.8 seconds (95%
other outcome measures.
Cl = -0.9 - 2.6) between 8 and 12 weeks was not significant (P = 0.164).
400
The differences in PD ratings during the stair test were
Table 2. Summary Statistics for Performance Measures Recorded Before and After 8 and 12 Weeks of
Pulmonary Rehabilitation

not significant among the 3 tests. Perceived dyspnea
decreased from a level 12 (between 'fairly easy to breath'
and 'somewhat short of breath') to 11 ('fairly easy to
breathe') after 8 weeks and remained at this level in week
12.
Pulmonary Function Status Scale
Twenty-six patients completed the Daily Activities/
Social Functioning and Psychological Functioning subscales and 10 patients completed the Sexual Functioning
subscale at the 3 test periods. The differences in the PFSS
total score were not significant among the 3 tests; nor were
the differences in the subscale scores.

Depression Scale
Twenty-eight patients completed the CDS at all 3 test
periods. The differences in the CDS total score were not
significant among the 3 tests.
DISCUSSION
After 8 weeks our patients were walking longer distances and reporting less dyspnea during the 6MWT and
descending and climbing stairs faster. The 6MWT increase
of 50 m (95% Cl 36.8 - 63.1) is consistent with the 54 m
change suggested by Redelmeier et all as the threshold of
Vol 16 ❖ No 3 -0- September 2005

350

E

250

Initial 8 weeks

12 weeks

Figure 1. The dashed trend line shows the curvilinear change (P = 0.05)
in walk distance over the 6MWTs administered during 12 weeks of pulmonary rehabilitation. Distance walked was significantly different
between initial test and 8 and 12 weeks ( P<0.001 ), but there was no difference in distance walked between 8 and 12 weeks (P=0.196).

To measure changes in functional status, we used the
1998 version of the PFSS. Although 11 patients showed
improvement in PFSS total score, the improvement for the
group overall was small (8%) and not statistically significant for either the PFSS total score or any of the 3 subscores. We estimate a sample of 58 patients would be
needed to have 80% power to declare the mean difference
of 0.70 (SD = 1.85) in the PFSS total score we observed
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after 12 weeks significant at P < 0.05. In contrast to our
results, Bowen et a120 and Haggerty et a1Z1 reported significant improvements of 10% to 22% in total and subscale
scores on an earlier version of the PFSS with a different
scoring system in 164 patients who participated in PR programs of variable duration.
As a self-report questionnaire, the PFSS is limited by the
patient's motivation, recall, and perception of improvement' and may be insensitive to detecting small changes in
function. Our patients rated themselves toward the higher
end of the ordinal scale on most items of the PFSS at the
initial test. The median scores were 3.5, 3.7, and 4.1 for
the Sexual Function, Psychological Function, and Activities/Social Function subscores, respectively. A rating of 3
indicates the patient has 'moderate difficulty' performing
the task; a rating of 4 indicates 'little difficulty' performing
the task. To achieve statistically significant and clinically
important changes in the PFSS, most of the patients would
need to have changed their ratings to 4 or 5. To rate a 5 on
the PFSS, the patient would have to believe they could perform the task 'without difficulty.' It is unlikely that patients
with chronic respiratory impairments would consider
themselves able to perform the activities of daily living on
the PFSS 'without difficulty' regardless of how effective the
PR program. The insensitivity of the ordinal rating scale
may explain why the PFSS data contradict the patients'
anecdotal reports of improved functioning in daily activities. Also, more individualized training in self-care, including activities of daily living and instrumental activities of
daily living may be needed to meet each patient's unique
functional needs at home and in the community and for
them to perceive changes in functional ability.
Depression and anxiety are common sequelae of
chronic respiratory disease,L2 but to our knowledge, there is
no disease-specific outcome measure for this population.
Instead generic instruments such as the Beck Depression
Inventory (BDI)2' are frequently used to measure depression. Unlike the BDI, the CDS addresses both depression
and anxiety in a single score and was developed for individuals with cardiovascular disease, a patient group that
also frequently undergoes outpatient rehabilitation.
Because the CDS contains no cardiac specific content,
Hare and Davis" suggested it could be used to measure
depression in other populations, and the American Association for Cardiovascular and Pulmonary Rehabilitation has
suggested it as an outcome tool for PR.24
Fifteen of 28 patients reported less depression on the
CDS after 8 and 12 weeks of PR. However, the improvement was small (< 1 % after 8 weeks, 5% after 12 weeks,
and 4.7% between 8 and 12 weeks) and not statistically
significant. The majority of patients' scores were within
one standard deviation of the mean score (80.3 ± 27.8)
reported by Hare and Davis" for their test population suggesting that our patients were not severely depressed. A
post-hoc statistical power analysis suggested 86 subjects
would be needed to have 80% power to declare mean difference of 2.5 (SD = 7.9) we observed after 8 weeks significant at P < 0.05.

Because we were unable to find any other published
reports that used the CDS, we are unable to compare our
results directly with other studies. Using the Hospital Anxiety and Depression scale, Withers et all' reported significant
decreases in depression among 95 patients with COPD after
6 weeks of PR. Kozora et a126 found significant decreases in
depression as measured by the BDI in a group of 30 patients
with COPD after 3 weeks of PR compared to a nonrandomized, medical comparison group of COPD patients not participating in PR. Both Withers et a124 and Kozora et a12i3 provided psychosocial services as part of their PR programs,
and Withers et al 14 employed a clinical psychologist as a
member of the multidisciplinary PR team. Their success
suggests that PR programs consider including specific medical or behavioral interventions as part of a comprehensive
PR program to help patients manage depression.
Patients with chronic pulmonary disease face the challenge of maintaining their functional capacity while experiencing diminished physiological function. Two studies
raise the important question of whether longer PR programs help participants to maintain the gains in functional
exercise capacity attained in 7 to 8 week programs. Grosbois et al 17 found that 18 months of physical therapistsupervised exercise maintenance once or twice a week or
daily home exercise maintenance were equally effective in
maintaining improvements in maximal workload attained
after 7 weeks (21 sessions) of outpatient PR. However, in
subjects who did not participate in exercise maintenance,
maximal workload returned to baseline after 18 months.
Swerts et a12' reported that after an 8-week (24 sessions) PR
program, subjects who completed an additional 12 weeks
(10 additional sessions) of supervised training maintained
their increased exercise tolerance 6 months and one year
after beginning the program. Subjects who received only
written instructions to continue exercise at home after the
8-week PR program showed a decline in exercise tolerance
after one year. Additionally, only 27% of subjects in the
latter group were still exercising at home one year later,
while 100% of subjects who had 20 weeks of PR continued their home exercise. That patients are more likely to
continue exercising after a longer PR program agrees with
the literature on life style change, which suggests people
are more likely to continue their new behavior after 6
months of training.29 Future research should investigate
ways to facilitate long-term behavioral changes in patients
who have completed a PR program.
A number of limitations result from the study's observational nature and relatively small convenience sample.
First, because the study was conducted within an on-going
PR program in a small hospital, only patients referred to the
PR program were eligible for the study. This introduced the
possibility of sampling bias. Second, although the sample
size provided adequate statistical power to evaluate
changes in ST time, distance walked in the 6MWT, and PD
during the 6MWT, the sample provided low power to evaluate changes in PD during the ST, and functional status and
depression. Failing to detect a significant change in these
variables may be a Type II error. Third, although the PR
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program included patients with obstructive or restrictive
forms of lung disease, the sample was too small to analyze
the outcomes of obstructive vs. restrictive patients as separate groups. A further limitation is that we did not examine any long-term outcomes such as continued participation in exercise after formal PR, or hospital and health care
utilization rates.
In conclusion, using a within-subject research design,
we evaluated the changes in 6MWT distance, stair-climbing time, perceived dyspnea while walking and climbing
stairs, functional status, and depression after 8 weeks (24
sessions) and 12 weeks (36 sessions) of PR. After 8 weeks,
our patients made significant improvements in distance
walked in 6 minutes, perceived dyspnea while walking,
and stair climbing time but not in functional status or
depression. With 12 more sessions of PR over 4 additional
weeks, patients continued to increase walk distance and
functional status, and to decrease stair climbing time and
depression while perceived dyspnea remained unchanged.
Additional research is needed to definitively determine
whether patients in PR for more than 8 weeks continue to
increase exercise performance, and functional and psychological status. Additional research can also determine what
specific self-care training, medical or behavioral interventions, and psychosocial supports most effectively reduce
patients' symptoms and increase their capacity to participate in physical and social activities.
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